Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Albany Molecular Research (AMRI) has signed a three-year supply and manufacturing agreement with Revolymer, a technology development company in the UK.
Subscribe to our email newsletter
As per the deal, AMRI will be the primary manufacturer and supplier of Rev7, AGC and other polymers present in Rev7 degradable gum products.
The agreement will be executed in accordance with the British Retail Consortium Global Standards for Food Safety and the recognized standards of good manufacturing practice.
AMRI chairman and CEO Thomas E D’Ambra said they look forward to working with Revolymer as it develops and further expands its line of products.
AMRI works on drug discovery and development projects and conducts manufacturing of active ingredients and pharmaceutical intermediates.